Sort by
Refine Your Search
-
Listed
-
Employer
- Institute of Photonic Sciences
- ICN2
- Nature Careers
- CRAG-Centre de Recerca Agrigenòmica
- Centre for Genomic Regulation
- FUNDACIÓ BOSCH I GIMPERA
- Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)
- Principe Felipe Research Center
- UNIOVI
- Universidade de Vigo
- Universitat Autònoma de Barcelona
- Universitat Rovira i Virgili
- 2 more »
- « less
-
Field
-
potent immunity against tumors. These viruses are genetically engineered and tested in vitro in tissue cultures and in vivo in mouse tumor models. About the role The candidate will be the entrepreneur
-
Technology (IRTA), Autonomous University of Barcelona (UAB), and University of Barcelona (UB). The Center is located at the UAB Campus, and currently hosts 200 members from across the world. Research Programs
-
) by the deadline of the programme's call in a relevant field of Biology, Biochemistry, Medicine, Biotechnology, Pharmacy, Biomedical Engineering, Chemistry, Physics, Materials Science, or related areas
-
strategies Nanoparticle, coating, and membrane production Materials characterization techniques In vitro assays with commercial and primary cells Preclinical trials Knowledge in technology transfer, clinical
-
strategies Nanoparticle, coating, and membrane production Materials characterization techniques In vitro assays with commercial and primary cells Preclinical trials Knowledge in technology transfer, clinical
-
atomic-layer-by layer engineer-ing of novel artificial metastable materials and interface superconductivity; (iv) studies of superconducting heterostructures, Josephson junctions, SQUIDS, nanowires, and
-
Materials and Devices (AEMD) group focuses on the material sciences and technology aspects of novel electronic materials, with a strong emphasis on graphene as well as other 2D materials (MoS2). The group
-
puzzles in a quantum simulation approach. Moreover, they allow one to engineer and investigate even richer variants of the model, which go beyond the realm of existing materials. In our group, we
-
problems in human health with cutting edge technology and through inter-disciplinary collaborations with world-class scientists and physicians in Beijing. CIMR will provide education and training
-
underlying human disease. The team brings together diverse expertise, ranging from work with mutant stem cell-derived beta cell organoids, engineered mouse models, single cell epigenomics, large-scale genetic